Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells by unknown
Zhang et al. SpringerPlus  (2016) 5:235 
DOI 10.1186/s40064-016-1910-5
RESEARCH
Sulforaphane induces apoptosis 
and inhibits invasion in U251MG glioblastoma 
cells
Zhen Zhang1, Chunliu Li1*, Li Shang2, Yuejuan Zhang3, Rong Zou1, Yan Zhan1 and Benjun Bi3
Abstract 
In recent studies, sulforaphane (SFN) has been seen to demonstrate antioxidant and anti-tumor activities. In the 
present study, the viability inhibition effects of SFN in U251MG glioblastoma cells were analyzed by MTS. Morphology 
changes were observed by microscope. Apoptotic effects of SFN were evaluated by annexin V binding capacity with 
flow cytometric analysis. Invasion inhibition effects of SFN were tested by the invasion assay. The molecular mecha-
nisms of apoptotic effects and invasion inhibition effects of SFN were detected by western blot and gelatin zymogra-
phy. The results indicated that SFN has potent apoptotic effects and invasion inhibition effects against U251MG glio-
blastoma cells. These effects are both dose dependent. Taken together, SFN possessed apoptotic activity on U251MG 
cells indicated by increased annexin V-binding capacity, Bad, Bax, cytochrome C expression, and decreased Bcl-2 and 
survivin expressions. SFN inhibited invasion in U251MG cells via upregulation of E-cadherin and downregulation of 
MMP-2, MMP-9 and Galectin-3.
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Background
Glioblastoma, the most commonly primary central nerv-
ous system tumor, is one of the most devastating cancers 
with a 15  months median survival and a 8–26  % 2-year 
survival rate (Hassler et  al. 2014; Messaoudi et  al. 2015; 
Nagasawa et  al. 2012). Despite research efforts, effective 
therapies for glioblastoma are limited. Chemotherapy, as 
one of the most important therapies, has been proved to 
improve survival in glioblastoma (Spiegel et al. 2007; Stupp 
et al. 2009; Yang et al. 2014). However, rapid emergence of 
tumor resistance and side effects of current chemothera-
peutic agents lowered the therapeutic effects and limited 
application (Chamberlain 2010; Chen et  al. 2013). Thus, 
novel anti-glioblastoma drugs with fewer side-effects and 
greater therapeutic efficiency are strongly demanded.
The poor prognosis of glioblastoma is ascribed to the 
rapid growth rate and the high invasiveness (Alifieris 
and Trafalis 2015; Onishi et al. 2013; Wurth et al. 2014). 
Therefore, an efficient chemotherapeutic agent must be 
able to inhibit both growth and invasion of glioblastoma 
cells. Besides, the agent must have low toxicity to normal 
cells and have no tumor resistance。
At present, natural products are the major sources of 
available anticancer drugs. Phytochemicals obtained 
from vegetables, fruits, teas, and medicinal plants have 
been extensively investigated for their anti-cancer activi-
ties due to their safety, low toxicity, and general availabil-
ity (Pratheeshkumar et al. 2012). Identifying their active 
ingredients and researching the molecular mechanisms 
of such ingredients is regarded as an attractive approach 
for drug development. Sulforaphane (SFN), first identi-
fied in broccoli sprouts and present at high concentra-
tions in most cruciferous vegetables, has been shown to 
be effective in cancer treatment. Studies showed that SFN 
could induce apoptosis, inhibit progression and metasta-
sis of many kinds of cancer cells (Chen et al. 2015). And, 
there is an increasing need for new drugs to treat high-
risk cancer patients with a higher selectivity for cancer 
cells and lower toxicity to normal cells. SFN has a safe 
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cytotoxicity profile towards the normal cells thus it can 
be utilized in the development of safe cancer treatment 
strategies (Hussain et al. 2013; Kallifatidis et al. 2011). In 
addition, sulforaphane can overcome the chemoresist-
ance of cancer cells (Lan et al. 2015; Pastorek et al. 2015).
Despite a great number of studies describing the chem-
opreventive and chemotherapeutic properties of sul-
foraphane in cancers, there is little information on the 
properties of sulforaphane in glioblastoma. In the present 
study, we examined the effects of SFN on U251MG glio-
blastoma cells. Our study aimed to provide a novel poten-
tial therapeutic agent for the treatment of glioblastoma. 
Our results indicated that SFN was effective in inhibiting 
the tumor growth and infiltration of U251MG cells.
Results
SFN inhibited viability and changed cell morphology 
of U251MG glioblastoma cells
The viability of U251MG cells was measured by MTS 
assay. U251MG cells were treated with the increasing 
doses of SFN (0, 10, 20 and 40 µM) for 24 h. MTS assay 
showed that SFN significantly reduced the viability of 
U251MG cells in a dose dependant manner (Fig. 1a). And 
we found that SFN obviously changed cell morphology. 
Following 24  h of SFN incubation, U251MG cells dem-
onstrated reduction of pseudopodia, a rounded shape, 
shrinkage, nuclear condensation and fragmentation 
(Figs. 1b, 2). These results indicated the potential apop-
tosis inducing effect and invasion inhibiting effect of SFN 
in U251MG cells for further analysis.
SFN induced apoptosis in U251MG glioblastoma cells
Based on the finding that SFN was associated with 
cell apoptosis, we further studied the potential influ-
ence of SFN on U251MG cell apoptosis. After treated 
with SFN for 24  h, the apoptosis ratios were detected 
by flow cytometry. As shown in Fig.  3, the apoptosis 
ratios of the control group was 4.03  ±  1.31  %. Respec-
tively, the apoptosis ratios of the U251MG cells treated 
with 10, 20, 40 µM SFN were 6.70 ± 1.54, 13.03 ± 2.11, 
and 30.40 ± 4.33 %. When treated with 10 µM SFN, the 
percentage of total apoptosis increased, but the differ-
ence was not statistically significant compared with the 
untreated group (P  >  0.05). Treated with ≥20  µM SFN, 
the apoptosis ratio was dramatically increased in a dose-
dependent manner (*P < 0.05).
SFN induced apoptosis in U251MG via regulating related 
proteins
Western blot analysis revealed that the expression levels 
of Bcl-2, Bax, Bad, cytochrome C in SFN-treated cells 
were upregulated, while the Bcl-2 and survivin expres-
sion levels were downregulated when compared with 
the control group (Fig. 4a). (b) Statistical analysis of Bax, 
Bcl-2 expression and the ratio of Bax/Bcl-2. At 10  µM 
SFN, no signifiant differences were observed compared 
with the control group (P  >  0.05). At 20 and 40  µM, 
P  <  0.05 versus the control group. (c) Statistical analy-
sis of Bad expression. SFN upregulated Bad expression 
in a dose dependent manner. (d) Statistical analysis of 
cytochrome C expression. At 20 and 40 µM, P < 0.05 ver-
sus the control group. (e) Statistical analysis of survivin 
expression. The Bax, Bad, cytochrome C, Bcl-2 and sur-
vivin expression levels were affected in a dose-dependent 
manner in the U251MG cells.
SFN inhibited invasion in U251MG glioblastoma cells
To determine whether SFN weakens the cell invasion 
potential, transwell matrigel invasion assays were con-
ducted. The cells invading through the matrigel were 
counted. The results showed that the cell numbers 
in the following groups (10, 20, 40  µM) treated with 
SFN for 24  h were significantly decreased versus con-
trol cells (0  µM) following a dose-dependent manner 
(Fig.  5). Clearly, SFN attenuated the cell motility ability 
significantly.
SFN inhibited invasion ability in U251MG via influencing 
E‑cadherin, Galectin‑3 and MMPs
E-cadherin, Galectin-3, MMP-2 and MMP-9 play 
important roles in cellular invasion. The results of west-
ern blot showed that the protein levels of E-cadherin 
was increased, Galectin-3, MMP-2 and MMP-9 were 
decreased significantly after SFN treatment (Fig. 6a). To 
determine whether the activities of MMP-2 and MMP-9 
were also influenced by SFN, we employed Gelatine 
zymography. As demonstrated in Fig.  6f, samples from 
SFN-treated cells had darker bands than the control 
cells at both 72 and 92 kDa. That indicates SFN is able to 
inhibit the activities of MMP-2 and MMP-9.
Discussion
Sulforaphane (SFN), which is purified from cruciferae, 
has been demonstrated to possess a number of pharma-
cological properties and is one of the most promising 
agents for the treatment of various cancer types (Clarke 
et al. 2008). The present study investigated the influence 
of SFN on glioblastoma cells.
The results of the MTS assay confirmed that SFN 
effectively reduced the growth of U251MG cells in a 
dose-dependent manner. Furthermore, at increasing con-
centrations of SFN, the cells became rounder and mar-
cider, which was the morphological characteristics of 
apoptosis.
Subsequently, the percentages of apoptosis were dis-
tinguished using an annexin V and PI method by flow 
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Fig. 1 SFN inhibited viability and changed cell morphology of U251MG cells. a U251MG cell lines were treated with 0, 10, 20 and 40 µM SFN for 
24 h. Cell viability was examined using MTS assay. Results were expressed as a percentage of control, which was considered as 100 %. Data are 
presented as the mean ± SD of three independent experiments. b Morphological changes of U251MG cells treated with different concentrations of 
SFN for 24 h (magnification, ×40). The cells were evidently reduced in size and their margins were unclear compared with the control group
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cytometric analysis. Promoting tumor cell apoptosis 
has been recognized as one of most important meth-
ods towards tumor treatment (Feng et  al. 2011; Lino 
and Merlo 2011). We found that SFN induced apop-
tosis of U251MG cells in an increasing trend. Upon 
treatment with 10 µM SFN, the percentage of total apop-
tosis increased, but the difference was not statistically 
significant compared with the untreated group (P > 0.05). 
Therefore, this SFN concentration was hypothesized to 
be relative low and unable to trigger further cell apop-
tosis that would be detected by annexin V and PI. By 
contrast, at 20 and 40 µM SFN, the apoptosis rates were 
identified to be significantly different compared with 
the control group (P < 0.05). In addition, certain studies 
have previously reported that SFN induced cell apoptosis 
in different cancer cell lines (Conzatti et al. 2014; Gupta 
et  al. 2014; Huang et  al. 2012), which is consistent with 
the results of our study.
The uncontrolled growth and diffuse infiltration of 
tumor cells are the major cause of recurrence and death. 
Effective anti-glioblastoma therapy should not only 
inhibit tumor cell growth, but also prevent invasion of 
cancer cells (Ranjit et  al. 2015). We further investigated 
the effects of SFN on the invasion ability of U251MG 
glioblastoma cells. The invasion assay showed that SFN 
inhibited invasion ability of U251MG cells. The results 
conformed with studies which demonstrated that SFN 
inhibited invasion in different cancer cell lines (Lee et al. 
2013; Lenzi et al. 2014; Shan et al. 2013). In short, SFN is 
a potential chemopreventive agent for glioblastoma.
Fig. 2 SFN inhibited viability and changed cell morphology of U251MG cells. Morphological changes of U251MG cells treated with different 
concentrations of SFN for 24 h (magnification, ×100). The cells were evidently reduced in size and their margins were unclear compared with the 
control group
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Fig. 3 SFN induced apoptosis. U251MG cells treated with 0, 10, 20, 40 µM SFN for 24 h. a The cells were stained with annexin V and PI. The percent-
ages of apoptosis were based on the cells present in the LR and UR quadrants. Total apoptosis percentage, indicating that SFN induced apoptosis 
in a dose dependent manner. b Statistical analysis of total apoptosis percentage. At 10 µM SFN, no signifiant differences were observed compared 
with the control group (P > 0.05). At 20 and 40 µM, P < 0.05 versus the control group. PI propidium iodide, LR lower right, UR upper right
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Fig. 4 SFN regulated expressions of Bcl-2, Bax, Bad, cytochrome C and survivin. a Expression of apoptosis-associated proteins in U251MG glioblas-
toma cells treated with SFN and the expression levels of Bcl-2, Bax, Bad, and cytochrome C were detected by western blot analysis using tubulin 
as a control. b Statistical analysis of Bad expression. c Statistical analysis of Bax, Bcl-2 expression and the ratio of Bax/Bcl-2. d Statistical analysis of 
cytochrome C expression. e Statistical analysis of survivin expression
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Fig. 5 SFN inhibited invasion. a U251MG glioblastoma cells were seeded in transwells pre-coated with matrigel and were treated with 0, 10, 20, 
and 40 μM SFN for 24 h, respectively. Then, randomly chosen at least 5 fields were photographed (×40), and the number of cells that invaded into 
the lower surface was calculated as a percentage of invasion. b Statistical analysis of total invasion percentage. The bar chart showed that the num-
ber of invasive cells was significantly lower in SFN-treated U251MG cells than that of control cells (*P < 0.05)
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Fig. 6 SFN regulated E-cadherin, Galectin-3, MMP-2 and MMP-9. a Expression of invasion-associated proteins in U251MG cells treated with SFN and 
b statistical analysis of E-cadherin expression. c Statistical analysis of Galectin-3 expression. d Statistical analysis of MMP-9 expression. e Statistical 
analysis of MMP-2 expression. f Activities of invasion-associated proteins in U251MG cells treated with SFN and g statistical analysis of MMP-9 activ-
ity. h Statistical analysis of MMP-2 activity. The expression levels of E-cadherin, Galectin-3, MMP-2 and MMP-9 were detected by western blot analysis 
using tubulin as a control. The activities of MMP-2, MMP-9 were detected by gelatine zymography. The results are representative of at least three 
independent experiments
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However, the molecular mechanisms vary depend-
ing on cell lines (Gupta et al. 2014). In the present study, 
we found that SFN could inhibit U251MG glioblastoma 
cells, but the molecular mechanisms through which 
SFN affects glioblastoma cells remain unclear. In order 
to clarify the exact mechanisms of apoptosis and inva-
sion inhibition effects in U251MG glioblastoma cells, we 
investigated the influence of SFN on the crucial proteins 
associated with apoptosis and invasion.
Mitochondria are central integrators and transducers 
of proapoptotic signals in apoptosis (Carloni et al. 2012; 
Deighton et  al. 2014). Bcl-2 family proteins play a cru-
cial role in the mitochondrial apoptosis pathway. To a 
large extent, the sensitivity of cells to apoptotic stimuli, 
depends on the proportion of Bax protein to Bcl-2 pro-
tein in the cells. When the proportion increases, the cell 
apoptosis rate rises. Bad is a negative regulation of Bax/
Bcl-2 heterodimer. It replaces Bax in a concentration 
dependent manner, and the free Bax form the homodi-
mer (Hattori et  al. 2000; Hutcheson et  al. 2015; Yang 
et  al. 1995). Formation of Bax/Bax homodimers lead to 
loss of mitochondrial outer membrane integrity and 
cytochrome C release into the cytoplasm, and then trig-
gers the occurrence of the whole apoptotic events. That 
means Bad mediates apoptosis by regulating the ratio of 
homodimer to heterodimer of Bax.
We studied apoptosis mechanism of SFN on glioblas-
toma through the comprehensive expression of Bcl-2, 
Bax, Bad and cytochrome C. According to the results of 
the present study, SFN downregulated the expression of 
Bcl-2, upregulated the expression of Bax, Bad, and the 
proportion of Bax/Bcl-2 proteins, which indicated that 
Bcl-2 family proteins are involved in the SFN triggered 
apoptosis in U251MG cells. Furthermore, caspases are 
key factors in the execution of apoptosis. Caspase-3 is the 
most critical apoptosis performer in the downstream of 
cascade, and the activation of caspases is largely depend-
ent on the release of cytochrome C (Xie et  al. 2015; Yi 
et  al. 2015). The present results demonstrated that the 
expression levels of cytochrome C were elevated follow-
ing SFN treatment. It is most likely that SFN induces 
apoptosis by elevating their upstream signal Bax-to-Bcl-2 
ratio resulting in cytochrome C escape to the cytoplasm 
where cytochrome C interacts with caspases signaling 
pathways. Meanwhile, SFN increased the expression of 
Bad which upregulated the homodimers of Bax. Analysis 
by synthesis, we concluded that the proapoptosis signal-
ing way of SFN in U251MG glioblastoma cells was SFN–
Bad–Bax/Bcl-2-cytochrome C-caspases.
Besides, survivin is the smallest and strongest mem-
ber of the inhibitor of apoptosis protein (IAP) fam-
ily that is selectively overexpressed in most common 
types of human cancers, and has been implicated in 
the control of cell division, inhibition of apoptosis, and 
tumor cell resistance to certain anticancer agents. Sur-
vivin is one of the most specific cancer antigens identified 
to date and blocks apoptosis via antagonizing caspases, 
It is expressed in over 80 % of glioblastomas, but rarely 
detectable in normal adult tissues. In human gliomas, 
the overexpression of survivin was closely associated 
with uncontrolled cell proliferation and the inhibition of 
apoptosis, high levels of survivin expression revealed to 
be correlated with a poor prognosis. We found that SFN 
downregulated survivin in U251MG cells. Therefore, sur-
vivin is an important target molecule of SFN.
In order to clarify the exact mechanisms of invasion 
inhibiting effects of SFN on U251MG glioblastoma cells, 
the expression and activity of key invasion proteins were 
examined.
Tumor cell invasion into the basement membrane is the 
fundamental steps that mediate the dissemination of cells 
from the primary site to distant secondary sites. In this 
process, matrix metalloproteinases (MMPs) play crucial 
roles. Studies showed that MMPs degraded extracellu-
lar matrix proteins to create space for invading glioblas-
toma cells, and activate signal transduction cascades that 
promote invasion. Several studies address the fact that 
MMPs especially MMP-2 and MMP-9 overexpressed in 
glioblastoma cells compared with normal brain tissue 
(Chintala et al. 1999; Nakada et al. 2003). And the inhibi-
tion of MMPs could significantly reduce the invasiveness 
of glioblastoma cells (Coniglio and Segall 2013). In our 
study, secretion of MMP-2 and MMP-9 from U251MG 
cells was decreased after administering SFN. We also 
found SFN reduced the activity of MMP-2 and MMP-9 in 
U251MG cells. That’s a main reason for invasion inhibi-
tion of SFN in U251MG glioblastoma cells.
E-cadherin was reduced or lost in the majority of gli-
oma tissues. E-cadherin plays a key role in cancer cell 
invasion. Galectin-3, one of the most important factors 
in cell invasion process, was reported to be modulated by 
MMPs, which plays a crucial role in glioma cell invasion. 
Studies showed that high levels of Galectin-3 expressed 
in high grade glioma (Le Mercier et al. 2010). These stud-
ies are consistent with our results that SFN downregu-
lated Galectin-3 and inhibited invasion in U251MG cells. 
Galectin-3 is an important target molecule of SFN in 
glioblastoma cells invasion progress.
Conclusions
In conclusion, SFN has potent apoptosis inducing effects 
and invasion inhibiting effects against U251 glioblastoma 
cells. These effects are dose dependent. The most likely 
mechanisms are the induction of apoptosis by Bad–Bax/
Bcl-2-cytochrome C signaling pathway and survivin, 
and inhibition of invasion by influencing E-cadherin, 
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Galectin-3, MMP-2 and MMP-9 (Fig. 7). This study sug-
gests that SFN may be a suitable candidate for glioblas-
toma treatment (Ciftci et al. 2015). However, to the best 
of our knowledge, numerous mechanisms are involved in 
SFN-induced apoptosis and invasion inhibition, further 
research is required to elucidate these.
Methods
Cell lines and culture
The glioblastoma cell lines, U251MG, were obtained 
from ATCC (Manassas, VA, USA). The cells were culti-
vated in DMEM/HIGH glucose culture medium contain-
ing 10  % fetal bovine serum (FBS), 100  U/ml penicillin 
and 100 U/ml streptomycin. Cells were grown at 37 °C in 
a humidified incubator containing 5 % CO2. The medium 
was refreshed every 2–3 days. Cells were trypsinized by 
trypsin. The cells in the logarithmic growth phase were 
used to conduct the experiments described as follows.
Reagents
Culture media were purchased from Hyclone (Logan, 
Utah, USA), FBS and penicillin–streptomycin were 
acquired from Invitrogen (Carlsbad, CA, USA). MMP-9 
antibody was purchased from Cell Signaling Technology, 
Inc (Shanghai, China). MMP-2 antibody was supplied 
by Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
Antibodies against Bax, Bad, Bcl-2, cytochrome C and 
α-tubulin were purchased from Proteintech Group, Inc 
(Chicago, USA). d, l-Sulforaphane (SFN) was acquired 
from Sigma (St Louis, MO, USA). MTS assay kit was 
purchased from Promega (Madison, USA). Transwell 
plates for invasion assay were bought from BD Bio-
sciences (Bedford, MA, USA). BCA protein assay kit was 
obtained from Thermo Scientific Pierce Protein Research 
Products (Rockford, IL., USA). Annexin V-FITC Apop-
tosis Assay Kit was acquired from Nanjing KeyGEN Bio-
tech (Nanjing, China).
MTS
Cells were seeded into 96-well culture plates at the rate 
of 5000  cells/well overnight. Different cell wells were 
treated with 0, 10, 20 and 40 µM SFN for 24 h. 20 µl pre-
warmed MTS reagent was added to each of the wells for 
an additional 1  h following treatment. The absorbance 
values were measured at 490 nm by a BioTek® microplate 
reader (SynergyTM, HT, USA). In the absence of cells, 
background absorbance of the medium was subtracted. 
Results were expressed as a percentage of control (0 µM 
SFN), which was considered as 100  %. Each assay was 
performed in triplicate, and the results were expressed as 
the mean ± SD.
Morphological observation
U251MG cells were seeded and grown in 6-well culture 
plates until they reached 70 % confluence. Then SFN was 
administered at concentrations of 0,10, 20 and 40  µM 
and cells were cultured for 24 h. Morphological changes 
were observed by an phase-contrast microscope at ×40 
and ×100 magnification (Leica, Germany) connected to a 
digital camera (Olympus, Japan).
Fig. 7 Signaling pathway of SFN in U251MG cells
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Flow cytometry analysis of apoptotic cells
Apoptosis was detected using annexin V-FITC/propid-
ium iodide (PI) staining followed by flow cytometry. After 
treated with SFN for 24 h, cells were collected and cen-
trifuged at 1000 rpm for 5 min. Then, cells were washed 
twice with cold PBS to remove excessive medium. Next, 
the cells were re-suspended at a concentration of 1 × 106 
cells/ml in binding buffer and incubated with annexin 
V-FITC and PI at room temperature for 15  min in the 
dark. A total of at least 10,000 cells were collected and 
analyzed by flow cytometry (FACSAria, BD, USA).
Western blot
Samples were separated on SDS-PAGE gels and then 
transferred to nitrocellulose membranes. Membranes 
were incubated overnight at 4  °C with primary antibod-
ies. Membranes were washed with TBS-T, and then incu-
bated with secondary antibody. The same membranes 
were stripped and reprobed with α-tubulin antibody for 
equal loading and normalization.
Cell invasion assays
Cell invasion was performed using BD BioCoat Matrigel 
invasion chambers (BD Biosciences, 8  µm) pre-coated 
with BD Matrigel matrix. The assay insert plates were 
prepared by rehydrating the BD matrigel with 300  ml 
pre-warmed serum-free medium at room temperature 
for 30 min. 1 × 105 of U251MG cells treated with differ-
ent concentrations of SFN (0, 10, 20, 40 µM) suspended 
in 300  µl medium without FBS were added separately 
onto the apical chambers, and 500 µl medium with 10 % 
fetal bovine serum was added in the lower chambers. 
After the cells were grown for 24 h, the cells on the api-
cal chambers were removed with a cotton swab. The 
invaded cells (or pseudopodia) on the bottom of the 
chamber were fixed with 100 % methanol for 20 min at 
−20  °C, then stained with 0.5  % crystal violet solution 
at room temperature for 20 min. After moving away the 
crystal violet solution, the cells were rinsed with distilled 
water until no excess dye was viewed. The invaded cells 
or pseudopodia were counted from 5 randomly selected 
areas, the images were photographed by camera with a 
Leica DM IRB microscope at ×40 magnification.
Gelatin zymography
Gelatin zymography has been widely used to meas-
ure the activity of matrix metalloproteinases MMP-2 
(gelatinase A) or MMP-9 (gelatinase B). Cells were 
incubated in serum-free medium for 24  h with differ-
ent concentrations of SFN (0, 10, 20, 40 µM) treatment. 
Medium with secreted MMP-2 and MMP-9 proteins 
was collected from an equal number of cells and was 
centrifuged at 2000 rpm for 10 min to remove cellular 
debris. Then we collected the supernatant and mixed it 
with equal amount of sample buffer for loading in the 
gel. The supernatants were separated at 4  °C in a 10 % 
SDS polyacrylamide gel containing 1 mg/ml gelatin as 
a protease substrate. In the process of electrophoresis, 
SDS is reversibly combined with MMPs of samples to 
destroy hydrogen bond and hydrophobic bond, and 
MMPs can’t decompose gelatin. After electrophoresis, 
in order to eluate SDS, the gels were washed in rena-
turing buffer (pH 7.5, 2.5  % Triton X-100) for 30  min, 
2 times; then incubated in fresh developing buffer 
(50 mM Tris–HCl, pH 7.5, 0.2 M NaCl, 10 mM CaCl2, 
0.02 % NaN3) at 37 °C for 42 h to renature gelatinases. 
The gel was incubated with staining buffer [0.5  % 
Coomassie Blue R-250, 30  % methanol, and 10  % ace-
tic acid)] and then destained with washing buffer (50 % 
methanol, 10 % acetic acid), compared with marker, the 
zymography band at the specific location (molecular 
weight 62) was confirmed as active MMP-2, at the spe-
cific location (molecular weight 92) was confirmed as 
MMP-9.
Statistical analysis
Statistical analysis was performed using Statistical Pack-
age for Social Science (SPSS) SPSS 18.0. Data were 
expressed as mean ± SD and were evaluated by Student’s 
t test or one-way ANOVA. Multiple between-group com-
parisons were performed using the Student–Newman–
Keuls (S–N–K) method. Every experiment was repeated 
at least three times. A P value <0.05 was considered to be 
statistically significant.
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